| Literature DB >> 33246449 |
Ting-Ying Wu1, Hsiu-Yueh Liu2, Chien-Yi Wu3, Hung-Cheng Chen4, Shun-Te Huang5,6, Ping-Ho Chen7,8,9,10.
Abstract
BACKGROUND: In end-of-life patients with advanced cancers, oral examination, oral care, and oral re-examination are crucial. Although oral symptoms are among the major complaints of end-of-life patients, few studies have focused on oral care in these patients. In this study, the association between oral symptoms and oral dryness among end-of-life patients was examined, and improvement of oral conditions after oral care interventions by a professional dentist was quantified.Entities:
Keywords: Advanced cancers; End-of-life; Mucositis; Oral debris; Oral dryness; Oral health assessment tool; Professional oral care; Prospective intervention study
Mesh:
Year: 2020 PMID: 33246449 PMCID: PMC7697385 DOI: 10.1186/s12904-020-00684-0
Source DB: PubMed Journal: BMC Palliat Care ISSN: 1472-684X Impact factor: 3.234
Fig. 1Flow chart of this study
Fig. 2The mucositis classification of WHO was examined by professional dentist. The presence of mucositis (grades I–IV) and absence of mucositis (grade 0) in end-of-life patients with advanced cancers. Representative diagrams: (a) No mucositis, (b) WHO grade 1, (c) WHO grade 2, (d) WHO grade 3; (e) WHO grade 4
Fig. 3The Clinical Diagnosis Classification of oral dryness patients was examined by professional dentist in end-of-life patients with advanced cancers. Representative diagrams: (a) Grade 0, (b) Grade 1, (c) Grade 2; (d) Grade 3
The clinical characteristics and cancer type distribution between males and females in end-of-life patients with advanced cancers
| Characteristics | End-of-life patients ( | χ2 / Fisher’s exact test | Mann- Whitney | |||||
|---|---|---|---|---|---|---|---|---|
| Total | Males ( | Females ( | ||||||
| n (%)/ Median (IQR) | ||||||||
| Age (yrs) | 62.0 | (58.0–72.0) | 61.0 | (58.0–72.8) | 68.0 | (60.0–72.0) | 0.462 | |
| Education level (yrs) | ||||||||
| ≤ 9 | 13 | (59.1%) | 7 | (70.0%) | 6 | (50.0%) | 0.415a | |
| > 9 | 9 | (40.9%) | 3 | (30.0%) | 6 | (50.0%) | ||
| BMI | 21.0 | (20.0–25.0) | 22.0 | (20.0–25.3) | 21.0 | (17.0–25.0) | 1.000 | |
| Estimated survival (days) | 9.0 | (4.0–19.0) | 9.0 | (2.5–18.5) | 12.0 | (4.0–19.0) | 0.509 | |
| ECOG status (bedridden time(%)) | ||||||||
| < 100% | 12 | (44.4%) | 5 | (41.7%) | 7 | (46.7%) | 0.795a | |
| 100% | 15 | (55.6%) | 7 | (58.3%) | 8 | (53.3%) | ||
| ADL | 0.0 | (0.0–10.0) | 0.0 | (0.0–0.0) | 0.0 | (0.0–15.0) | 0.290 | |
| Glasgow coma scale | 14.0 | (9.0–15.0) | 14.5 | (5.0–15.0) | 14.0 | (12.0–15.0) | 0.701 | |
| Palliative prognosis index | 8.0 | (6.0–14.3) | 10.5 | (5.0–14.8) | 8.0 | (6.0–11.3) | 0.547 | |
| Limb edema index (0–16 scores) | 3.0 | (0.5–7.0) | 2.0 | (0.0–4.0) | 5.0 | (1.0–7.0) | 0.154 | |
| Limb edema | ||||||||
| Index > 0 | 5 | (19.2%) | 3 | (27.3%) | 2 | (13.3%) | 0.620a | |
| Index =0 | 21 | (80.8%) | 8 | (72.7%) | 13 | (86.7%) | ||
| Bacterial amount level | ||||||||
| Low | 17 | (65.4%) | 10 | (83.3%) | 7 | (50.0%) | 0.110a | |
| High | 9 | (34.6%) | 2 | (16.7%) | 7 | (50.0%) | ||
| Colon, rectum, rectosigmoid junction and anus (%) | 7 | (25.9%) | 2 | (16.7%) | 5 | (33.3%) | 0.612a | |
| Trachea, bronchus and lung (%) | 6 | (22.2%) | 2 | (16.7%) | 4 | (26.7%) | ||
| Liver and intrahepatic bile ducts (%) | 3 | (11.1%) | 2 | (16.7%) | 1 | (6.7%) | ||
| Others | 11 | (40.7%) | 6 | (50.0%) | 5 | (33.3%) | ||
Data are n (%) or median (IQR)
Abbreviations: IQR interquartile range, BMI Body Mass Index, ECOG Eastern Cooperative Oncology Group, ADL Activities of Daily Living
aFisher’s exact test
bAsymptotic significance by Mann- Whitney U test
Distribution of clinical indexes and oral conditions between non-severe and severe oral dryness in end-of-life patients with advanced cancers
| End-of-life patients ( | χ2 / Fisher’s exact test | Mann- Whitney | ||||
|---|---|---|---|---|---|---|
| Oral dryness | ||||||
| NOD ( | SOD ( | |||||
| n (%)/ Median (IQR) | ||||||
| Gender | ||||||
| Males | 7 | (46.7%) | 5 | (41.7%) | 0.795 | |
| Females | 8 | (53.3%) | 7 | (58.3%) | ||
| Age (yrs) | 62.0 | (58.0–70.0) | 67.0 | (58.5–72.8) | 0.806 | |
| Education level (yrs) | ||||||
| ≤ 9 | 7 | (53.8%) | 6 | (66.7%) | 0.674a | |
| > 9 | 6 | (46.2%) | 3 | (33.3%) | ||
| BMI | 21.0 | (20.0–23.0) | 24.0 | (17.8–26.8) | 0.247 | |
| Estimated survival (days) | 9.0 | (4.0–21.0) | 10.0 | (4.3–15.0) | 0.826 | |
| ECOG status (bedridden time(%)) | ||||||
| < 100% | 6 | (40.0%) | 6 | (50.0%) | 0.603 | |
| 100% | 9 | (60.0%) | 6 | (50.0%) | ||
| ADL | 0.0 | (0.0–30.0) | 0.0 | (0.0–0.0) | 0.139 | |
| Glasgow coma scale | 14.0 | (8.0–15.0) | 14.0 | (9.3–15.0) | 0.878 | |
| Palliative prognosis index | 8.0 | (4.0–12.8) | 10.0 | (8.0–14.8) | 0.209 | |
| Limb edema index (0–16 scores) | 2.0 | (0.0–4.0) | 6.0 | (2.3–7.8) | 0.100 | |
| Limb edema | ||||||
| Index > 0 | 4 | (26.7%) | 1 | (9.1%) | 0.356a | |
| Index =0 | 11 | (73.3%) | 10 | (90.9%) | ||
| Bacterial amount level | ||||||
| Low | 8 | (53.3%) | 9 | (81.8%) | 0.217a | |
| High | 7 | (46.7%) | 2 | (18.2%) | ||
| Mucosa healthiness | ||||||
| Mucositis | ||||||
| (−) | 13 | (86.7%) | 4 | (33.3%) | 0.007a* | |
| (+) | 2 | (13.3%) | 8 | (66.7%) | ||
| Candida infection | ||||||
| (+) | 9 | (60.0%) | 10 | (83.3%) | 0.236a | |
| (−) | 6 | (40.0%) | 2 | (16.7%) | ||
| Oral bleeding | ||||||
| (+) | 3 | (20.0%) | 1 | (8.3%) | 0.61a | |
| (−) | 12 | (80.0%) | 11 | (91.7%) | ||
| Oral moisture | ||||||
| Sensation of oral dryness | ||||||
| (+) | 5 | (41.7%) | 9 | (100.0%) | 0.007a* | |
| (−) | 7 | (58.3%) | 0 | (0.0%) | ||
| Tongue with oral moisture machine at initial examination | 27.1 | (22.1–29.2) | 0.0 | (0.0–5.6) | 0.002* | |
| Buccal mucosa with oral moisture machine at initial examination | 28.5 | (26.1–31.0) | 20.4 | (0.0–27.5) | 0.014* | |
| Oral cleanliness | ||||||
| Oral debris | ||||||
| Mild | 12 | (80.0%) | 3 | (25.0%) | 0.004* | |
| Severe | 3 | (20.0%) | 9 | (75.0%) | ||
| Tongue coating index | 0.4 | (0.3–0.6) | 0.4 | (0.3–0.6) | 1.000 | |
| OHAT at initial examination | ||||||
| Total scores | 6.0 | (5.0–8.0) | 8.5 | (6.3–9.8) | 0.014* | |
| Lips | 1.0 | (1.0–2.0) | 1.0 | (1.0–2.0) | 0.422 | |
| Tongue | 1.0 | (1.0–1.0) | 1.0 | (1.0–2.0) | 0.019* | |
| Gums and tissues | 0.0 | (0.0–1.0) | 1.0 | (1.0–1.0) | 0.011* | |
| Saliva | 1.0 | (1.0–1.0) | 2.0 | (2.0–2.0) | < 0.001* | |
| Natural teeth | 1.0 | (0.0–2.0) | 1.0 | (0.0–1.0) | 0.437 | |
| Dentures | 0.0 | (0.0-NA) | 1.5 | (0.3–2.0) | 0.190 | |
| Oral cleanliness | 1.0 | (1.0–2.0) | 1.5 | (1.0–2.0) | 0.476 | |
| Dental pain | 0.0 | (0.0–0.0) | 0.0 | (0.0–0.0) | 0.371 | |
| Voice | ||||||
| Normal | 5 | (33.3%) | 0 | (0.0%) | 0.047a* | |
| Abnormal | 10 | (66.7%) | 12 | (100.0%) | ||
| Swallow | ||||||
| (+) | 8 | (57.1%) | 8 | (66.7%) | 0.701a | |
| (−) | 6 | (42.9%) | 4 | (33.3%) | ||
| MWST | ||||||
| Swallowing with neither cough nor wet hoarseness | 4 | (57.1%) | 2 | (40.0%) | 1.00a | |
| In addition to 4 points, could swallow saliva two additional times within the 30 s | 3 | (42.9%) | 3 | (60.0%) | ||
| MMO | 3.5 | (3.0–4.0) | 3.0 | (2.0–3.5) | 0.180 | |
Data are n (%) or median (IQR). NA not applicable
Abbreviations: IQR interquartile range, NOD Nonsevere Oral Dryness, SOD Severe Oral Dryness, BMI Body Mass Index, ECOG Eastern Cooperative Oncology Group, ADL Activities of Daily Living, OHAT Oral Health Assessment Tool, MWST Modified Water Swallowing Test, MMO Maximum Mouth Opening
aFisher’s exact test
bAsymptotic significance by Mann- Whitney U test
* Statically significant (p < 0.05)
Oral conditions associated with non-severe and severe oral dryness in end-of-life patients with advanced cancers
| End-of-life patients ( | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oral dryness | ||||||||
| NOD ( | SOD ( | |||||||
| n | (%) | n | (%) | ORa | 95% CI | AORb | 95% CI | |
| Mucositis | ||||||||
| (−) | 13 | (86.7%) | 4 | (33.3%) | 1.00 | 1.00 | ||
| (+) | 2 | (13.3%) | 8 | (66.7%) | 13.00 | (1.92–87.99)* | 14.93 | (1.95–114.38)* |
| OHAT total score | ||||||||
| < =8 | 14 | (93.3%) | 6 | (50.0%) | 1.00 | 1.00 | ||
| > 8 | 1 | (6.7%) | 6 | (50.0%) | 14.00 | (1.37–142.89)* | 17.97 | (1.45–223.46)* |
| Oral debris | ||||||||
| Mild | 12 | (80.0%) | 3 | (25.0%) | 1.00 | 1.00 | ||
| Severe | 3 | (20.0%) | 9 | (75.0%) | 12.00 | (1.95–73.97)* | 15.97 | (2.06–123.72)* |
Data are n (%)
Abbreviations: NOD Nonsevere Oral Dryness, SOD Severe Oral Dryness, OR Odds Ratio, AOR Adjusted Odds Ratio, 95% CI 95% confidence interval
aOdds ratios (OR) refer to risk of severe oral dryness versus non-severe oral dryness patients according to each variable by logistic regression model with OR, and 95% CI. OR > 1 indicates a higher likelihood of being a severe oral dryness
bAOR: adjusted odds ratio for gender, and age (years) by logistic regression model with AOR, and 95% CI. AOR > 1 indicates a higher likelihood of being a severe oral dryness
The improvement of oral symptom scores before and after oral care interventions in end-of-life patients with advanced cancers
| End-of-life patients ( | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oral care interventions | ||||||||
| Pre-intervention | Post-intervention | |||||||
| Day 1 | Day 4 | Day 7 | Cochran’s Q test | Friedman test | ||||
| n (%)/ Median (IQR) | ||||||||
| Mucosa healthiness | ||||||||
| Mucositis | ||||||||
| (+) | 47.1%a | 11.8%b | 0.0%b | 0.003* | ||||
| (−) | 52.9% | 88.2% | 100.0% | |||||
| Candida infection | ||||||||
| (+) | 68.8%a | 37.5%b | 43.8% | 0.015* | ||||
| (−) | 31.3% | 62.5% | 56.3% | |||||
| Oral bleeding | ||||||||
| (+) | 17.6% | 5.9% | 0.0% | 0.097 | ||||
| (−) | 82.4% | 94.1% | 100.0% | |||||
| Oral moisture | ||||||||
| Oral dryness | ||||||||
| SOD | 41.2% | 35.3% | 29.4% | 0.741 | ||||
| NOD | 58.8% | 64.7% | 70.6% | |||||
| Sensation of oral dryness | ||||||||
| (+) | 63.6%a | 27.3% | 9.1%b | 0.009* | ||||
| (−) | 36.4% | 72.7% | 90.9% | |||||
| Oral cleanliness | ||||||||
| Oral debris | ||||||||
| Severe | 52.9%a | 5.9%b | 11.8%b | 0.001* | ||||
| Mild | 47.1% | 94.1% | 88.2% | |||||
| Tongue coating index | 0.3 | (0.3–0.7) | 0.3 | (0.1–0.3) | 0.2 | (0.1–0.5) | 0.065 | |
| OHAT at initial examination | ||||||||
| Total scores | 7.0 | (6.0–9.0)a | 3.0 | (1.0–4.0)b | 2.0 | (0.0–4.0)b | < 0.001* | |
| Lips | 1.0 | (1.0–2.0)a | 0.0 | (0.0–0.5)b | 0.0 | (0.0–0.0)b | < 0.001* | |
| Tongue | 1.0 | (1.0–1.5)a | 1.0 | (0.0–1.0) | 1.0 | (0.0–1.0)b | 0.003* | |
| Gums and tissues | 2.0 | (1.5–2.0)a | 1.0 | (1.0–1.0)b | 1.0 | (1.0–1.0)b | < 0.001* | |
| Saliva | 1.0 | (1.0–2.0)a | 1.0 | (0.0–1.0) | 1.0 | (0.0–1.0)b | 0.001* | |
| Natural teeth | 1.0 | (0.0–2.0) | 1.0 | (0.0–2.0) | 1.0 | (0.0–2.0) | 1.000 | |
| Dentures | 0.0 | (0.0–2.0) | 0.0 | (0.0–1.5) | 0.0 | (0.0–1.5) | 0.368 | |
| Oral cleanliness | 1.0 | (1.0–2.0)a | 1.0 | (0.0–1.0) | 1.0 | (0.0–1.0)b | 0.002* | |
| Dental pain | 0.0 | (0.0–0.0) | 0.0 | (0.0–0.0) | 0.0 | (0.0–0.0) | 0.368 | |
| Voice | ||||||||
| Abnormal | 82.4% | 76.5% | 70.6% | 0.549 | ||||
| Normal | 17.6% | 23.5% | 29.4% | |||||
| Swallow | ||||||||
| (+) | 62.5% | 81.3% | 81.3% | 0.165 | ||||
| (−) | 37.5% | 18.8% | 18.8% | |||||
| MMO | 3.5 | (2.5–4.0) | 3.0 | (2.0–3.8) | 3.0 | (3.0–3.5) | 0.731 | |
Data are (%) or median (IQR)
Abbreviations: IQR interquartile range, NOD Nonsevere Oral Dryness, SOD Severe Oral Dryness, OHAT Oral Health Assessment Tool, MMO Maximum Mouth Opening
a, bDifferent upper case letters denote significant differences (p < 0.05) between groups by Cochran’s Q (asymptotic significances) / Friedman test (asymptotic significances) and their correspondent post hoc comparisons
Fig. 4The improvement effect of oral care in representative unconscious patients (n = 3). Representative diagrams: In No. 28 patient, (a). Pre-intervention (Day 1) (b). Post-intervention (Day 4) (c). Post-intervention. In No. 17 patient, (c). Pre-intervention (Day 1) (d). Post-intervention (Day 7). In No. 26 patient, (e). Pre-intervention (Day 1) (f). Post-intervention (Day 7)